Simple clinical variables predict liver histology in hepatitis C: Prospective validation of a clinical prediction model

References

• European Association for the Study of the Liver. EASL International Consensus Conference on Hepatitis C. Paris, 26–28 February 1999. Consensus statement. J Hepatol 1999; 30: 956–61
   PubMedGoogle Scholar
• National Institutes of Health Consensus Development Conference Statement: management of hepatitis C 2002 (10–12 June 2002). Gastroenterology 2002;123:2082–99.
   PubMedGoogle Scholar
• Perrillo RP. The role of liver biopsy in hepatitis C. Hepatology 1997; 26 Suppl 1: 57S–61S
   Google Scholar
• Poynard T, Ratziu V, Benmanov Y, Di Martino V, Bedossa P, Opolon P. Fibrosis in patients with chronic hepatitis C: detection and significance. Sem Liver Dis 2000; 20: 47–55
   PubMed Web of Science ®Google Scholar
• Strader DB, Wright T, Thomas DL, Seeff LB, American Association for the Study of Liver D. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004; 39: 1147–71
   PubMed Web of Science ®Google Scholar
• Romagnuolo J, Jhangri GS, Jewell LD, Bain VG. Predicting the liver histology in chronic hepatitis C: how good is the clinician?. Am J Gastroenterol 2001; 96: 3165–74
   PubMedGoogle Scholar
• Hytiroglou P, Thung SN, Gerber MA. Histological classification and quantitation of the severity of chronic hepatitis: keep it simple!. Sem Liver Dis 1995; 15: 414–21
   PubMedGoogle Scholar
• Hosmer DW, Lemeshow S. Model building strategies. Applied logistic regression, DW Hosmer, S Lemeshow. John Wiley & Sons, New York 1989; 82–134
   Google Scholar
• Dienstag JL. The role of liver biopsy in chronic hepatitis C. Hepatology 2002; 36 Suppl 1: S152–60
   Google Scholar
• Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000; 32: 477–81
   PubMed Web of Science ®Google Scholar
• Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431–5
   PubMed Web of Science ®Google Scholar
• Brunt EM. Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology 2000; 31: 241–6
   PubMed Web of Science ®Google Scholar
• Khan MH, Farrell GC, Byth K, Lin R, Weltman M, George J, et al. Which patients with hepatitis C develop liver complications?. Hepatology 2000; 31: 513–20
   PubMedGoogle Scholar
• Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614–8
   PubMed Web of Science ®Google Scholar
• Nord HJ. Biopsy diagnosis of cirrhosis: blind percutaneous versus guided direct vision techniques: a review. Gastrointest Endosc 1982; 28: 102–4
   PubMedGoogle Scholar
• Abdi W, Millan JC, Mezey E. Sampling variability on percutaneous liver biopsy. Arch Int Med 1979; 139: 667–9
   PubMedGoogle Scholar
• Schlichting P, Holund B, Poulsen H. Liver biopsy in chronic aggressive hepatitis. Diagnostic reproducibility in relation to size of specimen. Scand J Gastroenterol 1983; 18: 27–32
   PubMed Web of Science ®Google Scholar
• Andriulli A, Festa V, Leandro G, Rizzetto M. Usefulness of a liver biopsy in the evaluation of patients with elevated ALT values and serological markers of hepatitis viral infection: an AIGO study. Dig Dis Sci 2001; 46: 1409–15
   PubMedGoogle Scholar
• Assy N, Minuk GY. Serum aspartate but not alanine aminotransferase levels help to predict the histological features of chronic hepatitis C viral infections in adults. Am J Gastroenterol 2000; 95: 1545–50
   PubMed Web of Science ®Google Scholar
• Bonacini M, Hadi G, Govindarajan S, Lindsay KL. Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1997; 92: 1302–4
   PubMed Web of Science ®Google Scholar
• Fortunato G, Castaldo G, Oriani G, Cerini R, Intrieri M, Molinaro E, et al. Multivariate discriminant function based on six biochemical markers in blood can predict the cirrhotic evolution of chronic hepatitis. Clin Chem 2001; 47: 1696–700
   PubMed Web of Science ®Google Scholar
• Haber MM, West AB, Haber AD, Reuben A. Relationship of aminotransferases to liver histological status in chronic hepatitis C. Am J Gastroenterol 1995; 90: 1250–7
   PubMed Web of Science ®Google Scholar
• Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T, et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357: 1069–75
   PubMed Web of Science ®Google Scholar
• Imperiale TF, Said AT, Cummings OW, Born LJ. Need for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C. Am J Gastroenterol 2000; 95: 2328–32
   PubMedGoogle Scholar
• Park GJ, Lin BP, Ngu MC, Jones DB, Katelaris PH. Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis?. J Gastroenterol Hepatol 2000; 15: 386–90
   PubMed Web of Science ®Google Scholar
• Pohl A, Behling C, Oliver D, Kilani M, Monson P, Hassanein T. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Am J Gastroenterol 2001; 96: 3142–6
   PubMed Web of Science ®Google Scholar
• Poynard T, Bedossa P. Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups. J Viral Hepatitis 1997; 4: 199–208
   PubMed Web of Science ®Google Scholar
• Reedy DW, Loo AT, Levine RA. AST/ALT ratio > or = 1 is not diagnostic of cirrhosis in patients with chronic hepatitis C. Dig Dis Sci 1998; 43: 2156–9
   PubMed Web of Science ®Google Scholar
• Renou C, Muller P, Jouve E, Bertrand JJ, Raoult A, Benderriter T, et al. Relevance of moderate isolated thrombopenia as a strong predictive marker of cirrhosis in patients with chronic hepatitis C virus. Am J Gastroenterol 2001; 96: 1657–9
   PubMed Web of Science ®Google Scholar
• Sheth SG, Flamm SL, Gordon FD, Chopra S. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1998; 93: 44–8
   PubMed Web of Science ®Google Scholar
• The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20: 15–20
   PubMed Web of Science ®Google Scholar
• Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24: 289–93
   PubMed Web of Science ®Google Scholar
• Rossi E, Adams L, Prins A, Bulsara M, de Boer B, Garas G, et al. Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients. Clin Chem 2003; 49: 450–4
   PubMed Web of Science ®Google Scholar
• Poynard T, McHutchison J, Manns M, Myers RP, Albrecht J. Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin. Hepatology 2003; 38: 481–92
   PubMed Web of Science ®Google Scholar
• Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696–9
   PubMed Web of Science ®Google Scholar